Michael Bookman
CHIEF LEGAL OFFICER, SECRETARY · Immuneering Corp
- 2025
- Feb 5, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael Bookman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Thomas J. Schall - $101K in IMRX purchases and sales in the last 12 months
- Peter Feinberg - $87K in IMRX purchases and sales in the last 12 months
- Brett Matthew Hall - $36K in IMRX purchases and sales in the last 12 months
- Harold Eugene Brakewood - $25K in IMRX purchases and sales in the last 12 months
- Benjamin J. Zeskind - $11K in IMRX purchases and sales in the last 12 months
- Leah R. Neufeld - $11K in IMRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael Bookman?
Michael Bookman is a corporate insider, tracked as CHIEF LEGAL OFFICER, SECRETARY of Immuneering Corp (IMRX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Michael Bookman last file a Form 4?
The most recent primary Form 4 on record is dated 5 February 2026, one of 2 filings going back to 2025.
Has Michael Bookman been buying or selling stock?
Recorded transactions: 1 open-market purchase ($7K) and 0 open-market sales across all tracked filings.
